Published in Health Business Week, September 28th, 2007
"Tigecycline has been shown to bind to bone; thus, to minimize the amount of radioactivity binding to bone and to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.